UTGST Rate Amendments add specified medicines and food products and revise seat classifications across tax schedules. UTGST rate schedules are amended: 2.5% schedule adds Trastuzumab Deruxtecan, Osimertinib, Durvalumab; 6% schedule inserts extruded or expanded savoury or salted products under 1905 90 30; 9% schedule expands snack pellet description to include extruded or expanded savoury or salted products and substitutes the seats entry to cover 9401 seats other than specified subheadings, excluding aircraft and motor vehicle seats; 14% schedule adds seats of a kind used for motor vehicles under 9401 20 00. Amendments commence on the notified date.